Clinical Trial Update: NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation- Treatment Use Study [Phase 3]

View source ↗

Summary

The Phase 3 Treatment Use Study evaluating the NAVISTAR ThermoCool catheter for radiofrequency ablation of symptomatic paroxysmal atrial fibrillation was termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Paroxysmal Atrial Fibrillation

Drugs mentioned

• NAVISTAR ThermoCool Catheter

Snippet

Sponsor: Biosense Webster, Inc. | Conditions: Heart Diseases, Arrhythmia | Phase 3 | Status: TERMINATED | Results posted: 2014-01-22